| 1 |
35168393 | Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer. | 2022 Jan-Dec |
1 |
| 2 |
30565135 | Regulation of YAP/TAZ Activity by Mechanical Cues: An Experimental Overview. | 2019 |
1 |
| 3 |
29238070 | The interplay between mutant p53 and the mevalonate pathway. | 2018 Mar |
3 |
| 4 |
30176928 | The role of YAP/TAZ activity in cancer metabolic reprogramming. | 2018 Sep 3 |
1 |
| 5 |
26750334 | Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways. | 2016 Apr |
1 |
| 6 |
27155373 | Could drugs inhibiting the mevalonate pathway also target cancer stem cells? | 2016 Mar |
1 |
| 7 |
27713571 | HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes. | 2016 Oct 7 |
1 |